socalTECH

DECEMBER 15, 2020

Los Angeles-based life sciences investor Westlake Village BioPartners announced today that it has raised two new venture capital funds, worth a total of $500M, for its investments in biotech companies. The venture investor says it has now raised more than $820M in total for its investments.

Westlake Village 113

Westlake Village Funding Incubator San Diego 113

socalTECH

FEBRUARY 17, 2021

Los Angeles-based venture capital investor Westlake Village BioPartners said on Wednesday that it has named Peter Calveley, previously Managing Director in the Investment Banking Group at SVB Leerink, as its Chief Operating Officer. Calveley previously also served at Merrill Lynch and Alexion Pharmaceuticals.

Westlake Village 113

Westlake Village Venture Capital Los Angeles Invest 113

socalTECH

SEPTEMBER 5, 2018

Westlake Village BioPartners , a brand new venture capital fund focused on the life sciences, said on Wednesday that it has launched a new, $320 investment fund aimed at early stage companies. According to the new venture fund, it was founded by Beth Seidenberg, M.D.,

Westlake Village 100

Westlake Village Funding Venture Capital Research 100

socalTECH

DECEMBER 15, 2020

Los Angeles-based ACELYRIN , a new startup biopharma company, announced this morning that it has raised a Series A funding. Size of the funding round was not announced. The funding came from Westlake Village BioPartners. READ MORE>>.

Westlake Village 113

Westlake Village Funding Los Angeles Startup 113

Xconomy

SEPTEMBER 5, 2018

Los Angeles has long been in San Francisco’s shadow when it comes to life sciences investment. But a new venture capital firm led by industry veterans is trying to cast the City of Angels in a new light. Westlake Village BioPartners is launching today with $350 million in committed capital.

Westlake Village 73

Westlake Village Los Angeles Angel Venture Capital 73

socalTECH

SEPTEMBER 22, 2015

CoverHound , which has offices in Westlake Village, and is also one of the portfolio firms of Los Angeles-based venture investor Core Innovation Capital , has raised $33.3M in a Series C funding. The company now reportedly has a valuation of over $103M. READ MORE>>.

Westlake Village 100

Westlake Village Los Angeles Capital Invest 100

socalTECH

APRIL 28, 2016

Westlake Village-based Sienna Biopharmaceuticals , a new aesthetics and medical dermatology startup, said Thursday that it has raised $34M in a Series A financing round. The funding was led by ARCH Venture Partners, and also included Altitude Life Science Ventures, Partner Fund Management, and Venvest Capital, along with angels.

Westlake Village 100

Westlake Village Product Capital Funding 100